Meeting the specific demands of targeted cancer therapy trials through optimized, validated pharmacogenomic testing services.
Targets
Test Menu

The test menu provides a summary of fully validated tests performed in our CLIA/CAP accredited clinical reference laboratory. Upon request, MolecularMD offers full documentation of all sample extraction and analysis protocols and validation results. In addition, we can customize and further validate any assay to meet the specific demands and performance requirements that a trial may require. We also welcome site visits to view our testing facilities and discuss logistics with our clinical trial management specialists.

In addition to the test menu, MolecularMD continues to develop new assays that address biomarker applications across of host of tumor and sample types.

Typical platforms employed our validated molecular tests include:

  • Quantitative Reverse Transcription PCR
  • Direct Sequencing
  • High Resolution Melt Analysis
  • Allele Specific PCR

Targets

©2009 MolecularMD. All Rights Reserved.